Novartis AG (NVS)
168.62
+3.11
(+1.88%)
USD |
NYSE |
Feb 27, 16:00
170.45
+1.83
(+1.09%)
After-Hours: 20:00
Novartis Free Cash Flow : 15.32B for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Roche Holding AG | 15.07B |
| Amgen, Inc. | 8.10B |
| AstraZeneca PLC | 8.977B |
| Gilead Sciences, Inc. | 9.456B |
| GSK Plc | 5.712B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 2.254B |
| Cash from Investing (Quarterly) | -2.111B |
| Cash from Financing (Quarterly) | 1.713B |
| Free Cash Flow Per Share (Quarterly) | 0.6409 |
| Free Cash Flow to Equity (Quarterly) | -2.118B |
| Free Cash Flow to Firm (Quarterly) | 1.463B |
| Free Cash Flow Yield | 4.66% |